CD-44-negative, neuroblastoma-derived SK-N-DZ cells engineered to express CD-44 show that the interaction between HA and CD44 was partially responsible for the adenoviral-mediated enhancement effect. The gene discussed is CD44; the disease is neuroblastoma.